Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1988 | 1 |
2015 | 1 |
2016 | 1 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Histiocytic and Dendritic Cell Neoplasm"
Page 1
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.
Cancer Discov. 2016 Feb;6(2):154-65. doi: 10.1158/2159-8290.CD-15-0913. Epub 2015 Nov 13.
Cancer Discov. 2016.
PMID: 26566875
Free PMC article.
Histiocytic neoplasms are clonal, hematopoietic disorders characterized by an accumulation of abnormal, monocyte-derived dendritic cells or macrophages in Langerhans cell histiocytosis (LCH) and non-Langerhans cell histiocytosis (non-LCH) …
Histiocytic neoplasms are clonal, hematopoietic disorders characterized by an accumulation of abnormal, monocyte-derived de …
Langerhans Cell Histiocytosis of the Skull in a Burr Hole Site Covered with Hydroxyapatite Material.
Moteki Y, Yamada M, Shimizu A, Suzuki N, Kobayashi T.
Moteki Y, et al.
World Neurosurg. 2019 Feb;122:632-637. doi: 10.1016/j.wneu.2018.11.198. Epub 2018 Nov 29.
World Neurosurg. 2019.
PMID: 30503292
BACKGROUND: Langerhans cell histiocytosis (LCH) is a rare dendritic histiocytic disorder that affects the bones, especially the skull. Langerhans cell histiocytosis (LCH) developing in a burr hole site for chronic subdural hematoma is extremely rare. . …
BACKGROUND: Langerhans cell histiocytosis (LCH) is a rare dendritic histiocytic disorder that affects the bones, especi …
Item in Clipboard
Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study.
Ceci A, de Terlizzi M, Colella R, Balducci D, Toma MG, Zurlo MG, Macchia P, Mancini A, Indolfi P, Locurto M, et al.
Ceci A, et al.
Cancer. 1988 Dec 15;62(12):2528-31. doi: 10.1002/1097-0142(19881215)62:12<2528::aid-cncr2820621213>3.0.co;2-#.
Cancer. 1988.
PMID: 3056605
Clinical Trial.
Eighteen evaluable children with recurrent Langerhans' cell histiocytosis (LCH) which was resistant to standard therapy, were treated with etoposide (VP 16-213), 200 mg/m2/day for 3 days every 3 weeks, to study the efficacy and toxicity of this drug. ...No dose-limi …
Eighteen evaluable children with recurrent Langerhans' cell histiocytosis (LCH) which was resistant to standard therapy, were …
Item in Clipboard
Cite
Cite